‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address
In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science
Latest Statistics Show Decline In Deaths From Breast Cancer
“What Is Good For NCI Is Good For NIH,” Broder Says In Address
Proposed Deal Could Resolve Key Disputes At NSABP, Pitt
NIH Reconsiders Closing A Meeting Of Advisory Group
NIH Extramural Office Lists Initiatives For Reinvention
Trending Stories
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74









